4//SEC Filing
DAWES KAREN A 4
Accession 0000950170-25-074251
CIK 0000730272other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 3:27 PM ET
Size
14.2 KB
Accession
0000950170-25-074251
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
DAWES KAREN A
Director
Transactions
- Award
Common Stock
2025-05-15+973→ 92,096 total - Award
Stock Option (Right to Buy)
2025-05-15+1,800→ 1,800 totalExercise: $123.26From: 2026-05-15Exp: 2035-05-15→ Common Stock (1,800 underlying)
Footnotes (2)
- [F1]Ms. Dawes was awarded 973 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 15, 2026, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F2]Award vests in full on the earlier of May 15, 2026, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.
Documents
Issuer
REPLIGEN CORP
CIK 0000730272
Entity typeother
Related Parties
1- filerCIK 0001261506
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 3:27 PM ET
- Size
- 14.2 KB